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CD8 is oneof several cell surface glycoproteins implicated in variousT cell activa-
tion and effector functions . The subset ofT cells that express CD8 are restricted
in their antigen recognition by class I MHC molecules (1-3). The participation of
CD8 in MHC-restricted antigen recognition byT cells was suggested by findings
from several groups that anti-CD8 antibodies inhibited T cell antigen recognition
(4-11) . This inhibition was attributed to antibody-mediated interference with the
bindingofCD8 to its ligand, thought to be nonpolymorphic determinants on class
IMHC molecules . However, recent experimentshave indicated that anti-CD8 anti-
bodies may block T cell function by transducing a negative signal to the effector
T cell (12-16), an observation that has necessitated areinterpretation of earlier anti-
body blocking data . In view ofthe complexities of anti-CD8 antibody blocking studies,
alternative approaches are required to define the function of CD8.
Gene transfer technology offers amore direct approach forcharacterizing thefunc-
tion of T cell surface molecules . In two independent transfection studies of CD8
(17-19), reconstitution ofantigen specificityand classIMHC restrictionwas achieved
in murine CD8 - T cell hybridomas by stable transfer of the genes encoding CD8
and theTCR a and R chains . The use ofT cell hybridomas in these studies limited
the number of functions that could be evaluated . Transfection studies with human
T cell clones are advantageous because they allow for a more complete range offunc-
tional responses to be assessed .
In a recent study, we have linked anti-sense RNA mutagenesis and humanT cell
cloning technologies . Specifically, we demonstrated that surface expression ofCD8
was selectively inhibited by >95% using an EBV episome-based anti-sense RNA
expression system (20) . The antigen specificity of theT cell clone used in that study
was unknown, and therefore, effects on antigen recognition could not be assessed .
In this report, we describe the functional consequences of inhibiting CD8 expres-
sion in a human T cell clone with known antigenic specificity.
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Materials and Methods
Lymphoblastoid Cell Lines (LCL)' .
￿
Two human EBVtransformed lymphoblastoid cell lines,
AR.LCL (HLA haplotype: A28,32 ; B27,35; DR1,5) and DK.LCL (HLA haplotype: A2,24;
B13,50; DR2,7), were derived by a standard procedure (21) and used for these studies.
Derivation of the Human T Cell Clone jH.ARL.l.
￿
An HLA-B35-specific, CD8' human T
cell clone, JH.ARL.1, wasderived from a primary MLC ofhumanPBMC (HLA haplotype:
A2,3; B7,44; DR2,4) andallogeneic AR.LCL cells. Cloning was performedby limiting dilu-
tion in 96-well microtiter plates with 200 ul of complete medium per well supplemented with
10% MLA-144 culture supernatant (CS) as a source of IL-2 . To each well, we added 2 x
1041'-irradiated (5,000 rad) autologous PBMC and 5,000 y-irradiated (104 rad) AR.LCL cells.
The T cell clone JH .ARL.1 was stimulated weekly with irradiated AR.LCL cells (105
cells/ml), irradiated autologous PBMC (7 .5 x 105 cells/ml), and IL-2 (10% MLA-144 CS).
This stimulation protocol was followed for 4 wk after the cloningprocedure; then JH.ARL.1
cellswere stimulated weekly with OKT3 mAb (1 ng/ml; OrthoDiagnostic Systems Inc., West-
wood, MA), irradiated allogeneic PBMC (7.5 x 105 cells/ml), and IL-2. 3 d after stimula-
tion,JH.ARL.1 cells were washed and subcultured in fresh complete medium supplemented
with IL-2 (10% MLA-144 CS) for4dbefore restimulation. JH.ARL.1 was specific forHLA-
B35 as assessed by cytotoxicity against a panel of LCL targets.
Transfection and Selection ofStable Transfectants.
￿
Construction of the plasmids a-CD8/REPI
and RSVCATa/220.2 and the transfection/selection procedures have been described previ-
ously (20). Episomes were stably transfected into JH.ARL.1 by electroporation, and stable
transfectants were selected in mediacontaining hygromycin B (150 wg/ml; Calbiochem-Behring
Corp., La Jolla, CA).
Flow Cytometry.
￿
Expression of cell surface molecules was analyzed by indirect immunos-
taining as described previously (21, 22). The mAb WT31 (antiTCR a chain) was obtained
from Becton Dickinson &Co., Mountain View, CA, and OKT8, OKTII, and OKT3 mAbs
were from Ortho Diagnostic Systems Inc. Immunofluorescence of stained cells was assessed
on a flow cytometer (EPICS V; Coulter Electronics Inc., Hialeah, FL). Relative intensities
offluorescence were determined by preparinga standard curve usingbeadswith standardized
fluorescent intensities (Coulter Electronics Inc.) .
Cytotoxicity Assay.
￿
A standard 4-h "Cr-release assay, as described previously (21), was used
to assess the ability ofJH.ARL.1 cells to lyse alloantigen-specific, nonspecific, and lectin-
coated targets. JH .ARL.1 effector cellswere cocultured with LCLtargets or with K562 targets
and PHA (I gg/ml) in quadruplicate round-bottom wells of a 96-well microtiter plate (200
ltl/well). Spontaneous release of LCL and K562 targets was <26% and <8%, respectively.
Conjugate Formation Assay.
￿
The adhesion ofJH.ARL.1 T cell clones to fluorescein-labeled
LCL cells was assessed by a published method (23). 5 x 105 LCL cells/ml were incubated
for 10 min at room temperature in 0.1 mg/ml fluorescein diacetate, and were washed three
times. An equal number of labeled LCL cells and nonlabeled JH.ARL.1 cells (105 cellseach)
were added to conical centrifuge tubes, centrifuged, and incubated at room temperature for
30 min. The cellswere centrifuged again, then gently resuspended by usinga constant shear
force (fivecycles of a 50-gl Eppendorfpipette). Assays were coded and 250-350 fluorescence
cellswere counted foreach sample using afluorescence microscope. Aconjugate wasdefined
as a fluorescent cell bound to one or more nonfluorescent cells.
Proliferation Assay.
￿
A standard [3H]thymidine incorporation assay (21, 22) was used to
assess the proliferative response ofJH .ARL.l cells to antigen-specific and nonspecific stimuli.
An equal number of JH .ARL.1 cells (105 cells/well; 11 d post-anti-CD3 stimulation) were
cultured with irradiated LCL cells or with autologous PBMC and OKT3 (2 ng/ml) or PHA
(1 wg/ml) in quadruplicate wells of a 96-well microtiter plate (100 41/well). Cells were cul-
tured both in the presence and absence of exogenous IL-2 (10% MLA-144 CS). Cells were
pulsed with [3H]thymidine during the last 18 h of the 3-d culture period, then harvested,
and the amount of incorporated radioactivity was measured.
IL-2 Secretion Assay.
￿
Secretion of IL-2 by JH.ARL.1 was assessed as described previously
1 Abbreviations used in thispaper. CS, culture supernatant; LCL, lymphoblastoid cell line; RSV 3' LTR,
Rous sarcoma virus 3' long terminal repeat.(24). Briefly, IL-2 secretion was induced by incubating an equal number ofJH .ARL.1 cells
(106 cells/ml; 11 d post-anti-CD3 stimulation) with irradiated LCL cells for 18 h at 37°C
and 7% C02 . The supernatants from these cultures were collected and assayed for IL-2 ac-
tivity using a cloned human T cell line (5 d post-anti-CD3 stimulation) that requires IL-2
for proliferation. HL-2 (Collaborative Research, Lexington, MA) was used to standardize
the assay.
Stimulation ofIL-2-R Expression.
￿
IL-2-R expression was induced by incubatingJH.ARL.1
cells (2 x 105 cells/200 pl/well; 7 d post-anti-CD3 stimulation) with irradiated LCL cells in
96-well plates. LCL cells (2 x 105 cells/200 gl/well) were fixed before addition ofJH.ARL.1
cells by centrifuging the cells, removing the supernatant, and air-drying for 30 min at room
temperature. After incubation at 37°C and 7% C02 for 20 h, IL-2-R expression was as-
sessed by immunofluorescence staining using a murine anti-IL-2-R IgG mAb (anti-CD25;
Becton Dickinson & Co.) and flow cytometry.
Results
Selective Inhibition of CM Express= on JH.ARL.I.
￿
JH .ARL.1, a human CD8+ -
alloreactive T cell clone specific for HLA-B35, was derived from a primary mixed
lymphocyte culture using the human EBVtransformed B cell line AR.LCL as stimu-
lator. Stable hygromycin-resistant transfectants ofJH.ARL.1 were derived for the
episomes a-CD8/REP1 (with a 459-bp segment of CD8 cartridged in an anti-sense
orientation downstream of the Rous sarcoma virus 3' long terminal repeat [RSV
3' LTR] ; reference 20) and RSVCATa/220.2 (with the prokaryotic chloramphenicol
acetyltransferase gene driven by the same promoter).
The a-CD8/REPI transfectant, the RSVCATa/220.2 transfectant, and nontrans-
fected JH.ARL.1 cells were analyzed for expression of T cell surface molecules by
immunofluorescence staining and flow cytometry (Fig. 1). Expression of CD8 by
NON-TRANSFECTED
RSVCAT&/220.2 Ó
a
w
i
a-CD8/REP I
0
Û
HAMBOR ET AL.
FIGURE l.
￿
Flow cytometric anal-
yses of CD8, C132, CD3, and
TCR surface expression on
transfected and nontransfected
JH.ARL.1 cells. The a-CD8/
REPI transfectant, the RSV
JH.ARL.I
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OKT8 (anti-CM), WT31 (anti-
TCR ß chain) (shaded areas), or
normal mouse Ig (open areas) as
primary antibodies; FITC-
conjugated goat anti-mouse
IgG was used as the secondary
antibody. The x-axis represents
256 channels logarithmically
distributed over three decades.
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the a-CD8/REP1 transfectant was markedly inhibited (>977o) in comparison with
nontransfected JH.ARL.1 cells and the RSVCATa/220.2 transfectant. Expression
of CD2, CD3, and TCR was not altered in either of the transfected cell lines com-
pared with the nontransfected parent. Theseresults parallel those previously reported
for the transfected clone 8L2 (20), and they demonstrate that efficient and selective
inhibition ofCD8 expression canbe obtained in T cell clones usingan EBVepisome-
based expression system.
Requirementfor CD8 in Alloantigen-specific Cytotoxicity byJH.ARL.1.
￿
The effects on
Tcell function ofselectively inhibiting cell surfaceCD8expression were investigated.
The ability of the a-CD8/REP1 transfectant to mediate lysis of antigen-specific,
antigen-nonspecific, and lectin-coated targets was determined using a standard "Cr-
release assay (Fig. 2). Lysis of an antigen-specific target (AR.LCL) by the a-CD8/
REPI transfectant was inhibited at all E/T ratios examined in comparison with lysis
by nontransfectedJH .ARL.1 cells or the RSVCATa/220.2 transfectant. Even at the
highest E/T ratio (20:1), antigen-specific cytotoxicity mediated by the a-CD8/REPI
transfectant was less than that mediated by controls at an E/T ratio of 2.5:1. None
of the effector cells were capable of killing a nonspecific target (DK.LCL; HLA-
B35-), demonstrating that cytotoxicity was not inappropriately expressed in the
transfected cell lines. To determine whether the cytotoxic machinery ofJH.ARL.1
was affected by loss of CD8 surfaceexpression, we studiedlectin-dependent cytotox-
icity. The parental cloned line and both transfectants could efficiently lyse lectin-
coated targets (PHA-coated K562). Thus, anti-sense RNA-mediated inhibition of
CD8 expression in an antigen-specific Tcell clone markedly inhibitedlysisof antigen-
specific targets without affecting lectin-mediated killing.
Since cytolytic activity requires conjugate formation between effector and target
cells, we next examined the ability of a-CD8/REP1 transfectant cells to form con-
jugates. Inhibition ofCD8 expression on theJH.ARL.1 clone did not affect the ability
of these cells to conjugate with either HLA-1135+ or HLA-1135 - cells (data not
shown). This result suggests that the inhibition of antigen-specific cytotoxicity in
the CD8- variant is not explained by interference with the initial nonspecific adhe-
sion events (25, 26) in T cell-mediated target cell lysis. It seems likely that the de-
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Cytolyticactivity of
the a-CD8/REPI transfectant
and control JH.ARL.1 cells
against antigen-specific, antigen-
nonspecific, and lectin-coated
targets. AR.LCL, DK.LCL,
and K562 cells were labeled
with 51Cr and used as targets
in a standard 4-h 5'Cr-release
assay. Effector cells (nontrans-
fected JH.ARL.1, "; the
RSVCATa/220.2 transfectant,
/; the a-CD8/REPI transfec-
tant, A) were used at various
E/Tratios. PHA was included
in assays with K562 targets.HAMBOR ET AL.
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creased expression ofCD8 inhibits antigen-specific recongnition ofa class I MHC
product.
RoleofCD8inAlloantigen-triggered Proliferation.
￿
Another event associatedwith TCR-
transduced antigen-specific recognition is proliferation. The ability of the a-CD8/
REP1 transfectant to proliferate in response to stimulation by irradiated LCLcells,
irradiated PBMC, and anti-CD3 mAbs, orirradiated PBMC and PHAwasassessed
using a [3H]thymidine incorporation assay (Table I). Whereas nontransfected
JH.ARL.1 cells and the RSVCATa/220.2 transfectant proliferated in response to
stimulation by AR.LCL cells (HLA-B35'), the proliferative response ofthe a-CD8/
REP1 transfectant to stimulation by AR.LCL was significantly decreased. This de-
crease was still evident even with exogenous IL-2 added to the culture. In contrast
to the marked decrease in antigen-specific stimulation, anti-CD3- or PHA-mediated
proliferative responses were unaffected in the a-CD8/REP1 transfectant. This re-
sult demonstrates thatinhibition ofCD8expression on analloantigen-specific T cell
clonedecreases its abilityto proliferatein response to alloantigenic stimulation without
affecting proliferation induced by stimuli that do not involve antigenic recognition
(anti-CD3 or PHA plus PBMC).
Since proliferation of T cell clones is mediated by IL-2 and is dependent upon
induction ofIL-2-R expression, we measured IL-2 secretion (Table II) and IL-2-R
expression (datanot shown) afteralloantigenic stimulationofJH.ARL.1. Nontrans-
fected JH.ARL.1 cells and the RSVCATa/220.2 transfectant secreted IL-2 and ex-
pressed IL-2-R when stimulated with AR.LCL cells (HLA-B35'), whereas pro-
found decreases in both IL-2 secretion and IL-2-R expression were observed for
the a-CD8/REPI transfectant. These results indicate the dependence of antigen-
TABLE I
Proliferative Response ofJKARL.1
JH.ARL.1 cells (11 days post-anti-CD3 stimulation) were cocultured with irradiated LCL cells or with ir-
radiated PBMC and anti-CD3 or irradiated PBMC and PHA. Cultures were incubated in the absence ( - )
or presence ( + ) of exogenous IL-2 (10% MLA-144 CS) for 3 d. [3H]Thymidine was added during the last
18 h of the incubation period. SD of means >1,000 dpm were <10% of the means and have been omitted.
AR.LCL is the specific target for JH.ARL.1, and DK.LCL is an unrelated cell line.
Stimulus IL-2
JH.ARL.I
nontransfected
[3H]Thymidine incorporation
JH.ARL.1
RSVCATa/220.2
JH.ARL.I
a-CD8/REP1
dpm
- - 83 65 65
AR.LCL - 25,674 25,564 3,591
DK.LCL - 168 223 197
PBMC - 149 134 189
PBMC + anti-CD3 - 88,769 78,062 89,997
PBMC + PHA - 36,121 32,008 39,202
- + 3,576 2,067 2,696
AR .LCL + 36,574 35,667 4,532
DK.LCL + 2,636 2,587 2,732
PBMC + 1,827 1,966 1,889
PBMC + anti-CD3 + 96,287 87,319 110,633
PBMC + PHA + 65,727 59,821 66,8031242
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TABLE II
IL-2 Production by ,JH.ARL.I
JH.ARL.I cells (11 d post-anti-CD3 stimulation) were cocultured with irradiated LCL cells.
Supernatants were harvested after incubation for 18 h and assayed for IL-2 activity on an
IL-2-dependent indicator cell line. SD of means >I,000 dpm were <10% of the means and
have been omitted. Background level of thymidine incorporation was 210 dpm, and optimal
responses at 2 .5 U/ml of rIL-2 was 8,986 dpm . AR.LCL is the specific target forJH.ARL.1,
and DK .LCL is an unrelated cell line.
stimulated responses, including secretion of the lymphokine IL-2 and acquisition
of IL-2-R, on the expression of the surface molecule CD8.
Discussion
We have used an anti-sense CD8 episomal expression construct to derive aCD8-
variant of an allospecific, nontransformed human T cell clone. This stably trans-
fected clone was markedly inhibited in a number of T cell functional responses to
alloantigenic stimulaton, including cytotoxicity, proliferation, lymphokine secretion,
andlymphokine receptor expression. In contrast to TCRdependent activation, this
CD8- T cell variant could still mediate functions elicited by lectin or anti-CD3 .
CD8 on T cells is thought to directly bind to class I MHC products on target
cells (27, 28) in a fashion analogous to the direct binding of CD4 to class II MHC
products (29) . Along with this trans interaction, CD8 is postulated to associate in
a cis interaction with the TCR/CD3 complex on the same T cell. The TCR/CD3
complexand CD8 have been shown to comodulate from the cell surface afterspecific
antigenic stimulation (30, 31). By decreasing surface expression of CD8, we have
eliminated the interactions that are essential for optimal activation of T cell func-
tional responses requiring antigen recognition through the TCR/CD3 complex.
Previous findings that anti-CD8 antibodies inhibit anti-CD3- or lectin-mediated
cytotoxic and proliferative responses of CD8+ clones have suggested that a nega-
tive signal transduction event occurs by perturbation of surface CD8 or that anti-
CD8 inhibits positive signal transduction (12-16). Our data do not directly address
this important issue, but it is interesting to note that marked inhibition of CD8 sur-
face expression did not either positively or negatively affect effector functions elicited
by anti-CD3 or lectin fortwodistinct human T cell clones, 8L2 (20) andJH.ARL.1.
If signal transduction via CD8 is significant in the absence of the addition of anti-
CD8 mAbs, some alteration would be expected in the CD8- variants in anti-CD3
or lectin-mediated responses. To date we have not found any evidence for this type
of alteration.
The finding that conjugation was not altered by the loss of surface CD8 suggests
that effects on conjugation do not explain the observed functional defects in the
CD8- variant. Studies of the effects of anti-CD8 mAbs on conjugate formation have
Stimulus
[3H]Thymidine
JH.ARL.I
nontransfected
incorporation into IL-2-dependent
JH.ARL. I
RSVCATa/220.2
indicator cell line
JH.ARL.1
a-CD8/REP1
dpm
- 197 230 182
AR.LCL 8,327 7,815 976
DK.LCL 213 182 256HAMBOR ET AL.
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reported contradictory results (5, 23, 32-34). Our findings using mutational anal-
ysis demonstrate that CD8 is notnecessary for nonspecific conjugation, an interac-
tion that is presumably mediated by LFA-1/ICAM-1 and CD2/LFA-3 ligand-receptor
pairs (35, 36).
In no case were the functional deficits in the CD8- variant reduced to back-
ground levels. This finding might be explained by the presence of residual surface
CD8, or alternatively, there could be alowlevel of non-CD8-dependent stimulation
occurring in the antigen-specific functional assays that could be mediated by the
TCR alone. Nonetheless, it is clear that a >97% decrease in CD8 surface expres-
sion dramatically inhibited antigenic stimulation ofallofthe effector functions tested.
We have developed an alternative approach fordefining the function ofT cell mol-
ecules by applying anti-sense RNAmutagenesisto the analysis ofhumanT cell clones.
The use of a nontransformed human T cell clone has allowed us to assess an array
of functions requiring antigen-specific recognition that could not be assessed with
murine hybridomas. Ourprocedure does not requirethe use ofexogenous antibodies,
thereby obviating the difficulties in interpretation of such studies. The transfection
of anti-sense expression vectors into human T cell clones represents a different ap-
proach for analyzingthe functions of T cell surface molecules. In this case, we have
demonstrated that CD8 is necessary for antigen recognition ofaclass IMHC product
by an allogeneic human T cell clone.
Summary
An experimental approach for defining the function of CD8 has been developed
by linking anti-sense RNA mutagenesis and T cell cloning technologies. We have
transfected an anti-sense CD8 episomal expression vector into a CD8+ nontrans-
formed human T cell clone that is specific for the human class I alloantigen HLA-
B35. Expression ofCD8 on this Tcell clone, JH.ARL.1, wasselectively andefficiently
inhibited. Stimulation of this CD8- variant with specific alloantigen resulted in a
marked loss of a number of functional responses, including cytotoxicity, prolifera-
tion, IL-2 secretion, and IL-2-R expression. However, thesesame functional responses
could be elicited with stimuli that do not require antigen recognition to activate the
T cell (anti-CD3 mAbs, PHA). The resultsofour study supportthehypothesis that
CD8 is required for recognition of class I MHC alloantigens that results in activa-
tion of T cell functional responses.
We thank R. Groger, H.-K. Shu, and R. Getty for theirwork in plasmid construction, and
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Cechner for her help in manuscript preparation.
Receivedforpublication 17 May 1988 and in revisedform 5July 1988.
References
1. Reinherz, E. L., and S. F. Schlossman. 1980. The differentiation and function ofhuman
T lymphocytes. Cell. 19:821.
2. Meuer, S. C., S. F Schlossman, and E. L. Reinherz. 1982. Clonal analysis of human
cytotoxic T lymphocytes: T4' and T8' effector T cells recognize products of different
major histocompatibility complex regions. Proc. Natl. Acad Sci. USA. 79:4395.
3. Swain, S. L. 1983. Tcell subsets andtherecognition of MHC class. Immunol. Rev. 74:129.1244
￿
ANTI-SENSE RNA-MEDIATED INHIBITION OF CD8
4. Swain, S. L. 1981. Significance of Lyt phenotypes: Lyt2 antibodies block activities of T
cells that recognize class 1 major histocompatibility complex antigens regardless of their
function. Proc. Nad. Acad. Sci. USA. 78:7101.
5 . Landegren, U., U. Ramstedt, I. Axberg, M. Ullberg, M. Jondal, and H. Wigzell. 1982.
Selective inhibition ofhuman T cell cytotoxicity at levels of target recognition or initia-
tion of lysis by monoclonal OKT3 and Leu-2a antibodies. J Exp. Med. 155:1579.
6. Swain, S. L., D. P Dialynas, F. W. Fitch, and M. English. 1984. Monoclonal antibody
to L3T4 blocks the function of T cells specific for class 2 major histocompatibility com-
plex antigens. J Immunol. 132 :1118.
7 . Spits, H., H. Yssel, A. Voordouw, and J. E. de Vries. 1985. The role of T8 in the cyto-
toxic activity of cloned cytotoxic T lymphocyte lines specific for class II and class I major
histocompatibility complex antigens. J Immunol. 134:2294.
8. Schimonkevitz, R., B. Luescher, J.-C. Cerottini, and H. R. MacDonald. 1985. Clonal
analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen
expression : correlation between antigen density and requirement for Lyt-2/3 function.
J Immunol. 135:892 .
9. Goldstein, S. A. N., and M. F. Mescher. 1987 . Cytotoxic T cell activation by class I
protein on cell-size artificial membranes: antigen density and Lyt-2/3 function. J Im-
munol. 138:2034.
10. Aparicio, P., D. Jaraquemada, and J. A. Lopez de Castro. 1987 . Alloreactive cytolytic
T cell clones with dual recognition of HLA-B27 and HLA-DR2 antigens. Selective in-
volvement of CD8 in their class I-directed cytotoxicity J. Exp. Med. 165:428.
11 . Moldwin, R. L., W. L. Havran, G. J. Nau, D. W. Lancki, D.-K. Kim, and E W. Fitch.
1987. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven
activation of cloned murine T cells. J Immunol. 139:657.
12 . Welte, K., E. Platzer, C. Y. Wang, E. A. R. Kan, M. A. S. Moore, and R. Mertelsmann.
1983 . OKT8 antibody inhibits OKT3-induced IL-2 production and proliferation in
OKT8' cells. J Immunol. 131:2356.
13 . Hunig, T. 1984. Monoclonal anti-Lyt-2.2 antibody blocks lectin-dependent cellular cy-
totoxicity of H-2-negative target cells. J Exp. Med. 159:551 .
14. Fleischer, B., H. Schrezenmeier, and H. Wagner. 1986. Function of the CD4 and CD8
molecules on human cytotoxic T lymphocytes: regulation ofT cell triggering.J Immunol.
136:1625.
15 . Van Seventer, G. A., R. A. W. Van Lier, H . Spits, P. Ivanyi, and C. J . M. Melief. 1986.
Evidence for a regulatory role of the T8 (CD8) antigen in antigen-specific and antiT3-
(CD3)-induced lytic activity of allospecific cytotoxic T lymphocyte clones. Eur. J. Im-
munol. 16:1363.
16. Geppert, T. D., and P E. Lipsky. 1986. Accessory cell-T cell interactions involved in anti-
CD3-induced T4 and T8 cell proliferation: analysis with monoclonal antibodies. J Im-
munol. 137 :3065.
17 . Dembic, Z., W. Haas, S. Weiss, J. McCubrey H. Keifer, H. von Boehmer, and M. Stein-
metz. 1986. Transfer ofspecificity by murine a and Q Tcell receptor genes. Nature (Lond.).
320:232 .
18. Dembic, Z., W. Haas, R. Zamoyska, J . Parnes, M. Steinmetz, and H. von Boehmer.
1987 . Transfection ofthe CD8 gene anhances T-cell. recognition. Nature (Load.). 326:510 .
19. Gabert, J., C. Langlet, R. Zamoyska, J . R. Parnes, A.-M. SchmittVerhulst, and B.
Malissen. 1987. Reconstitution ofMHC class I specificity by transfer ofthe T cell receptor
and Lyt-2 genes. Cell. 50:545.
20. Hambor, J. E., H.-K. Shu, R. K. Groger, C. A. Hauer, D. R. Kaplan, and M. L.
Tykocinski. 1988. Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-HAMBOR ET AL.
￿
1245
mediated gene inhibition in a human cytotoxic T-cell clone. Proc. Nad. Acad Sci. USA.
85:4010.
21 . Kaplan, D. R., R. Griffith, V. L. Braciale, and T. J. Braciale. 1984. Influenza virus-
specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restric-
tion by class II MHC products. Cell. Immunol. 88 :193.
22 . Kaplan, D. R., V. L. Braciale, and T. J. Braciale. 1984. Antigen-dependent regulation
of interleukin 2 receptor expression on cloned human cytotoxic T lymphocytes. j Im-
munol. 133:1966.
23 . Mentzer, S. J., B. R. Smith, J. A. Barbosa, M. A. V. Crimmins, S. H . Herrman, and
S. J. Burakoff. 1987. CTL adhesion and antigen recognition are discrete steps in the
human CTL-target cell interaction. f. Immunol. 138:1325 .
24. Kaplan, D. R., C. A. Bergmann, D. Gould, and B. Landmeier. 1988. Membrane-associated
interleukin 2 epitopes on the surface of human T lymphocytes. ,J. Immunol. 140:819.
25. Spits, H., W. Schooten, H . Keizer, G. Seventer, M. Rijn, C . Terhorst, and J. de Vries.
1986. Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells
and target cells. Science (Wash. DC). 232:403
26. Shaw, S., G. Luce, R. Quinones, R. Gress, T. Springer, and M . Sanders. 1986. Two
antigen-independent adhesion pathways used by human cytotoxic Tcell clones. Nature
(Lond). 323:262.
27 . Norment, A., and D. Littman. 1988. Human CD8 binds class I molecules. FASEB (Fed.
Am. Soc. Exp. BioL) J. 2:A870 (Abstr.).
28. Rosenstein, Y., S. Ratnofsky, S. Burakoff, and S. Herrmann. 1988. Direct evidence that
CD8 and class I molecules interact to mediate adhesion. FASEB (Fed. Am. Soc. Exp. BiOL)
f. 2 :A871 (Abstr.).
29. Doyle, C., andJ. L. Strominger. 1987 . Interaction between CD4 and class II MHC mol-
ecules mediates cell adhesion. Nature (Lond.). 330:256.
30 . Emrnrich F., U. Strittmatter, and K. Eichmann. 1986. Synergism in the activation of
human CD8 T cells by cross-linking the Tcell receptor complex with the CD8 differenti-
ation antigen. Proc. Natl. Acad. Sci. USA. 83:8298.
31 . Takada, S., and E. G. Engleman. 1987. Evidence for an association between CD8 mole-
cules and the T cell receptor complex on cytotoxic T cells. J. Immunol. 139:3231.
32 . Blanchard, D., C. van Els, J. Borst, S. Carrel, A. Boylston, J. E. de Vries, and H. Spits.
1987. The role ofthe T cell receptor, CD8, and LFA-1 in different stages of the cytolytic
reaction mediated by alloreactive T lymphocyte clones. J. Immunol. 138 :2417.
33 . Spits, H., W. van Schooten, H . Keizer, G. van Seventer, M van de Rijn, C. Terhorst,
and J. E. de Vries. 1986. Alloantigen recognition is preceded by nonspecific adhesion
of cytotoxic T cells and target cells. Science (Wash. DC). 232:403.
34 . Platsoucas, C. D. 1984. Human T cell antigens involved in cytotoxicity against allogeneic
or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with
effector-target cell binding and of the T3/Leu 4 antigen with triggering. Eur j Immunol.
14:566.
35 . Springer, T. A., M. L. Dustin, T. K. Kishimoto, and S. D. Marlin. 1987. The lympho-
cyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of
the immune system. Annu. Rev. Immunol. 5:223 .
36. Marlin, S. D., and T. A. Springer. 1987. Purified intercellular adhesion molecule-1 (ICAM-
1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell. 51:813.